While the impact of Medicaid changes on employer-sponsored insurance remains to be seen, competition between providers is a steadfast way to stabilize the system for everyone, according to Christoph Dankert, chief network officer of Carrum Health.
Market competition is a powerful and underutilized tool in the health policy space, according to Christoph Dankert, chief network officer of Carrum Health, who recently sat down with Managed Healthcare Executive to talk about the shifting landscape of healthcare payments.
“As a company, what we have seen work is harnessing the power of the market’s competition,” Dankert said in a video interview. “We find providers who are cost-effective and very high quality and then they get rewarded with more business. If that provider isn't cost-effective anymore, then we'll go out and take another look at the market. We believe that if there is more competition between providers, that can lead to more efficiencies. This idea to use competition to drive efficiencies is a very powerful one, and I don't think we've seen enough of that on the health policy side.”
Christoph Dankert
Dankert also said that while he isn’t worried about how healthcare networks could handle potential Medicaid cuts, their response depends on how the cuts are structured.
“There are 160 million individuals who have insurance through their employer or their spouse’s employer or their parents’ employer, and so I think even if there are mercurial changes in Medicaid eligibility, that's probably only a fraction of that 160 million,” Dankert said.
Dankert also emphasized that from a commercial perspective, it’s important that networks have enough space capacity for a potential influx of uninsured individuals.
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen